Pfizer Balance Sheet Annual

Trade

BSE: 500680 | NSE: PFIZER | ISIN: INE182A01018 | Sector: Major Drugs

5,241.00 +18.95 (0.36%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	2,046.71	28.70	34.00	100.07
Short Term Investments	13.02	1,805.92	1,550.15	943.86
Cashand Short Term Investments	2,059.73	1,846.42	1,620.39	1,102.54
Accounts Receivable- Trade Net	187.61	151.73	124.27	129.69
Total Receivables Net	187.61	192.95	248.13	324.69
Total Inventory	433.69	417.70	448.90	435.05
Other Current Assets Total	88.53	60.98	71.78	57.36
Total Current Assets	2,769.56	2,525.09	2,396.48	1,924.71
Property/ Plant/ Equipment Total- Gross	0.40	415.11	401.21	336.06
Property/ Plant/ Equipment Total- Net	151.35	185.46	220.07	195.14
Goodwill Net	527.49	527.49	527.49	527.49
Intangibles Net	34.27	44.23	94.55	144.87
Long Term Investments	14.28	13.02	45.48	29.56
Note Receivable- Long Term	464.24	607.28	568.50	430.03
Other Long Term Assets Total	267.59	98.16	47.94	14.10
Total Assets	4,228.78	4,000.73	3,900.51	3,265.90
Accounts Payable	166.23	217.06	263.94	283.74
Notes Payable/ Short Term Debt	2.50	2.50	2.50	2.50
Current Portof LT Debt/ Capital Leases	37.69	38.65	36.75	60.73
Other Currentliabilities Total	340.14	353.97	499.46	379.88
Total Current Liabilities	546.56	657.35	852.89	774.34
Capital Lease Obligations	54.35	93.32	127.74	42.68
Total Long Term Debt	54.35	93.32	127.74	42.68
Total Debt	94.54	134.47	166.99	105.91
Other Liabilities Total	32.33	42.76	55.47	55.84
Total Liabilities	633.24	793.43	1,036.10	872.86
Common Stock Total	45.75	45.75	45.75	45.75
Retained Earnings( Accumulated Deficit)	3,549.79	1,835.00	1,495.72	1,031.52
Total Equity	3,595.54	3,207.30	2,864.41	2,393.04
Total Liabilities Shareholders' Equity	4,228.78	4,000.73	3,900.51	3,265.90
Total Common Shares Outstanding	4.57	4.57	4.57	4.57
Tangible Book Valueper Share Common Eq	663.15	576.11	490.16	376.12
Cash	-	11.80	36.24	58.61
Prepaid Expenses	-	7.04	7.28	5.07
Accumulated Depreciation Total	-	-229.65	-181.14	-140.92
Accrued Expenses	-	45.17	50.24	47.49
Additional Paid- In Capital	-	1,320.67	1,320.67	1,320.67
Other Equity Total	-	5.88	2.27	-4.90